Live Breaking News & Updates on Ovel Therapeutic Products

Stay updated with breaking news from Ovel therapeutic products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Qualigen Therapeutics, Inc. Announces Closing of $8.82

CARLSBAD, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced. ....

Tony Schor , David Kugelman , Exchange Commission , A Gp Alliance Global Partners , Atlanta Capital Partners , Qualigen Therapeutics Inc , Investor Awareness Inc , University Of Louisville , Alliance Global Partners , Qualigen Therapeutics , Orphan Drug , Private Securities Litigation Reform Act , Capital Partners , Nasdaq Qlgn , Qualigen Therapeutics , Nasdaq Qlgn , Institutional Investors , Alliance Global Partners , Ovel Therapeutic Products , Vn 247 ,